| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |